Clinical Trial Update: A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of HSK21542 Injection in Subjects Undergoing Hemodialysis [Phase 2]

View source ↗

Summary

Phase 2 trial update on HSK21542 injection for uremic pruritus in hemodialysis patients (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uremic Pruritus

Drugs mentioned

• HSK21542

Snippet

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: Uremic Pruritus | Phase 2 | Status: COMPLETED